Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Posters by Title

Type your Poster Title, then hit apply

Showing 1,267 results.

Thumbnail for Cost-Effective Analysis of Teclistamab and Daratumumab vs Ciltacabtagene Autoleucel in Relapsed Multiple Myeloma

CT - 422

Cost-Effective Analysis of Teclistamab and Daratumumab vs Ciltacabtagene Autoleucel in Relapsed Multiple Myeloma

Muhammad Bilal Abid

Poster Presenter: Muhammad Bilal Abid

Thumbnail for Could Day +30 T-Cell Exhaustion Biomarkers Guide Maintenance Choice Post Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma?

MM - 064

Could Day +30 T-Cell Exhaustion Biomarkers Guide Maintenance Choice Post Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma?

Yasmin Abdelsalam

Poster Presenter: Yasmin Abdelsalam

Previous 1...29 30 31 32 33 34 35...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for COVID-19 Co-infection as an Emerging Driver of Sepsis-Related Inpatient Mortality in Chronic Lymphocytic Leukemia: A 2020-2022 National Inpatient Sample Analysis

CLL - 368

COVID-19 Co-infection as an Emerging Driver of Sepsis-Related Inpatient Mortality in Chronic Lymphocytic Leukemia: A 2020-2022 National Inpatient Sample Analysis

Anas Mardini

Poster Presenter: Anas Mardini

Thumbnail for CPX-351 vs Standard of Care as Bridging to AlloHCT in Patients With Higher-Risk Myelodysplastic Neoplasms or Oligoblastic Acute Myeloid Leukemia: Results of the Randomized Phase 2 PALOMA Study

MPN - 756

CPX-351 vs Standard of Care as Bridging to AlloHCT in Patients With Higher-Risk Myelodysplastic Neoplasms or Oligoblastic Acute Myeloid Leukemia: Results of the Randomized Phase 2 PALOMA Study

Uwe Platzbecker

Poster Presenter: Uwe Platzbecker

Thumbnail for CR/CRi and MRD Outcomes With Intensive vs Low-Intensity Chemotherapy in AML: A Single-Center Retrospective Analysis

AML - 1020

CR/CRi and MRD Outcomes With Intensive vs Low-Intensity Chemotherapy in AML: A Single-Center Retrospective Analysis

Bret Miller

Poster Presenter: Bret Miller

Thumbnail for CRAB-Related Complication Burden in Multiple Myeloma Hospitalizations: Mortality, Organ Support, and Resource Utilization in the National Inpatient Sample Database

MM - 1133

CRAB-Related Complication Burden in Multiple Myeloma Hospitalizations: Mortality, Organ Support, and Resource Utilization in the National Inpatient Sample Database

Priyanka Nagdev

Poster Presenter: Priyanka Nagdev

Thumbnail for CRHBP Activates NF-?B Signaling Through TNIP1 Inhibition in Leukemic Stem Cells: A Novel CRH-Independent Mechanism of Treatment Resistance

AML - 109

CRHBP Activates NF-?B Signaling Through TNIP1 Inhibition in Leukemic Stem Cells: A Novel CRH-Independent Mechanism of Treatment Resistance

Ryutaro Taenaka

Poster Presenter: Ryutaro Taenaka

Thumbnail for CRISPR-Cas9 Targeting of CXCR4 in WHIM Syndrome as a Strategy to Overcome Microenvironmental Resistance in B-Cell Malignancies

ABCL - 300

CRISPR-Cas9 Targeting of CXCR4 in WHIM Syndrome as a Strategy to Overcome Microenvironmental Resistance in B-Cell Malignancies

Albert Owusu-Ansah

Poster Presenter: Albert Owusu-Ansah

Thumbnail for CRISPR/Cas9-Mediated SHP2 Knockout in Jurkat T Cells Using Neon and MaxCyte Electroporation Platforms: Establishment and Validation of a Model for SHP2-Driven Resistance Mechanisms

AML - 150

CRISPR/Cas9-Mediated SHP2 Knockout in Jurkat T Cells Using Neon and MaxCyte Electroporation Platforms: Establishment and Validation of a Model for SHP2-Driven Resistance Mechanisms

Kashif Ali

Poster Presenter: Kashif Ali

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors